Health-related quality of life (HR-QOL) and chronic health conditions in survivors of childhood acute myeloid leukemia (AML) with Down syndrome (DS): A report from the Children's Oncology Group Journal Article


Authors: Schultz, K. A. P.; Chen, L.; Kunin-Batson, A.; Chen, Z.; Woods, W. G.; Gamis, A.; Kawashima, T.; Oeffinger, K. C.; Nicholson, H. S.; Neglia, J. P.
Article Title: Health-related quality of life (HR-QOL) and chronic health conditions in survivors of childhood acute myeloid leukemia (AML) with Down syndrome (DS): A report from the Children's Oncology Group
Abstract: Survival rates for children with Down syndrome (DS) and acute myeloid leukemia (AML) are high; however, little is known regarding the health-related quality of life (HR-QOL) of these survivors. Individuals who survived Z5 years following diagnosis of childhood AML were invited to complete parent or patient-report surveys measuring HR-QOL and chronic health conditions. In total, 26 individuals with DS had a median age at diagnosis of 1.8 years (range, 0.77 to 10.9 y) and median age at interview of 15 years (range, 8.3 to 27.6 y). Participants with DS and AML were compared with AML survivors without DS whose caregiver completed a HR-QOL survey (CHQ-PF50). In total, 77% of survivors with DS reported Z1 chronic health condition compared with 50% of AML survivors without DS (P=0.07). Mean physical and psychosocial QOL scores for children with DS and AML were statistically lower than the population mean, though not discrepant from AML survivors without DS. Although the overall prevalence of chronic health conditions in survivors with DS is higher than in survivors without DS, prior studies of children with DS have reported similarly high rates of chronic health conditions, suggesting that AML therapy may not substantially increase this risk. Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.
Keywords: leukemia; chemotherapy; quality of life; down syndrome
Journal Title: Journal of Pediatric Hematology/Oncology
Volume: 39
Issue: 1
ISSN: 1077-4114
Publisher: Lippincott Williams & Wilkins  
Date Published: 2017-01-01
Start Page: 20
End Page: 25
Language: English
DOI: 10.1097/mph.0000000000000707
PROVIDER: scopus
PMCID: PMC5161561
PUBMED: 27906794
DOI/URL:
Notes: Article -- Export Date: 2 February 2017 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Kevin Oeffinger
    296 Oeffinger